The Burden of COVID-19 Survivorship

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

27 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-04

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research study is being done to find out what the longer-term physiological consequences of COVID-19 are, and to determine if exercise therapy can help improve lung function, heart function and overall fitness, and reduce symptoms in people recovering from SARS-CoV-2.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Feasibility and Safety of High-intensity Exercise Training in Patients Surviving COVID-19

NCT04549337

COVID-19

COMPLETED NA

The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19

NCT04647734

COVID-19, SARS-CoV2

COMPLETED NA

Aerobic Exercise in People With Post-COVID-19

NCT05302973

COVID-19

COMPLETED NA

Exercise and Post-COVID/ Long-COVID: Effects of Different Training Modalities on Various Parameters in People Affected by the Sequelae of COVID-19

NCT05204511

Long COVID-19 Post-COVID-19 Syndrome COVID-19

COMPLETED NA

Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients

NCT04613050

Covid 19 Infection

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this research is to see if taking part in structured exercise training will improve the ability to exercise, the function of the lungs and the function of the heart, and reduce symptoms of fatigue and breathlessness in people recovering from COVID-19. After enrollment all patients will complete exercise testing, lung function testing, and cardiac imaging. Patients will be randomized to either 8 weeks of exercise training (4-5 times per week) or will continue standard medical care. All patients will undergo detailed exercise testing, lung function testing, and cardiac imaging after the intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

Standard physician-guided medical care after COVID-19

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventional (exercise training) Group

8 week home-based exercise training

Group Type EXPERIMENTAL

Exercise Training

Intervention Type OTHER

8 week home-based exercise therapy 4-5 times/week

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise Training

8 week home-based exercise therapy 4-5 times/week

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 21 to 75 years.
* History of RT-PCR proven SARS-CoV-2 infection.
* Deemed 'recovered' from SARS-CoV-2 infection.
* Not clinically obese (BMI ≥ 36) and/or suffer from musculoskeletal or other conditions that would limit exercise participation.
* No evidence of cardiac ischemia at rest or during exertion (via ECG).
* Able to provide written informed consent.

Exclusion Criteria

* Individuals less than 21 or more than 75 years old.
* Not able to take part in structured exercise training due to injury or other conditions that would put person at risk during exercise.
* Unable to provide written informed consent.

Minimum Eligible Age

21 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No